Open Access Article
This Open Access Article is licensed under a Creative Commons Attribution 3.0 Unported Licence
Correction: Surface modification of intraocular lenses with hyaluronic acid and lysozyme for the prevention of endophthalmitis and posterior capsule opacification
Bailiang Wangab,
Quankui Lin*ab,
Tingwei Jinc,
Chenghui Shenb,
Junmei Tanga,
Yuemei Hana and
Hao Chen*ab
aSchool of Ophthalmology & Optometry, Eye Hospital, Wenzhou Medical University, Wenzhou, 325027, China. E-mail: lqk97531@126.com; Chenhao823@mail.eye.ac.cn; Fax: +86 577 88067962
bWenzhou Institute of Biomaterials and Engineering, Chinese Academy of Sciences, Wenzhou, 32500, China
cDepartment of Basic Teaching, City College of Wenzhou University, Wenzhou, 325027, China
First published on 7th March 2022
Abstract
Correction for ‘Surface modification of intraocular lenses with hyaluronic acid and lysozyme for the prevention of endophthalmitis and posterior capsule opacification’ by Bailiang Wang et al., RSC Adv., 2015, 5, 3597–3604, DOI: 10.1039/c4ra13499k.
The authors regret to inform that, the representative images of waterborne S. aureus adhesion on pristine PMMA, HA-5% lysozyme in Fig. 2 and growth and morphology of HLECs adhesion on TCPS were incorrectly marked (Fig. 2a, 2c and 6a, respectively). The corrected versions are shown below. The correction does not change any description, results or conclusions of the original paper.
 | ||
| Fig. 2 SEM images of (a) pristine PMMA and (b) HA, (c) HA-5% lysozyme, (d) HA-10% lysozyme, (e) HA-20% lysozyme coated on PMMA after exposure to waterborne S. aureus. | ||
 | ||
| Fig. 6 Growth and morphology of HLECs stained with FDA after 24 h of incubation on (a) TCPS, (b) pristine PMMA, (c) HA, (d) HA-5% lysozyme, (e) HA-10% lysozyme and (f) HA-20% lysozyme, under fluorescence microscopy (the magnification is 10×). | ||
The Royal Society of Chemistry apologises for these errors and any consequent inconvenience to authors and readers.
| This journal is © The Royal Society of Chemistry 2022 |